Related Experiment Video
Updated: Apr 19, 2026
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin
Xiang Zhang1, Shu-Li Cheng2, Ka Bian3,4
1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, the Fourth Military Medical University, Xi'an, Shaanxi, China.
Abstract:
Metastasis is the major reason for the death of patients suffering from malignant diseases such as human hepatocellular carcinoma (HCC). Among the complex metastatic process, resistance to anoikis is one of the most important steps. Previous studies demonstrate that microRNA-26a (miR-26a) is an important tumor suppressor that inhibits the proliferation and invasion of HCC cells by targeting multiple oncogenic proteins. However, whether miR-26a can also influence anoikis has not been well established. Here, we discovered that miR-26a promotes anoikis of HCC cells both in vitro and in vivo. With a combinational analysis of bioinformatics and public clinical databases, we predicted that alpha5 integrin (ITGA5), an integrin family member, is a putative target of miR-26a. Furthermore, we provide experimental evidence to confirm that ITGA5 is a bona fide target of miR-26a. Through gain- and loss-of-function studies, we demonstrate that ITGA5 is a functional target of miR-26a-induced anoikis in HCC cells. Collectively, our findings reveal that miR-26a is a novel player during anoikis and a potential therapeutic target for the treatment of metastatic HCC.
Insights
MicroRNA-26a (miR-26a) promotes anoikis, a crucial step in preventing cancer spread, in hepatocellular carcinoma (HCC) cells. This finding identifies miR-26a as a potential therapeutic target for metastatic HCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastasis is a primary cause of cancer-related mortality, particularly in hepatocellular carcinoma (HCC).
- Anoikis resistance is a critical factor in cancer cell metastasis.
- MicroRNA-26a (miR-26a) is known to suppress HCC proliferation and invasion, but its role in anoikis is unclear.
Purpose of the Study:
- To investigate the role of miR-26a in anoikis of HCC cells.
- To identify potential targets of miR-26a involved in anoikis.
- To explore miR-26a as a therapeutic target for metastatic HCC.
Main Methods:
- Bioinformatic analysis and public clinical database interrogation to predict miR-26a targets.
- In vitro and in vivo experiments to assess miR-26a's effect on anoikis.
- Gain- and loss-of-function studies to validate alpha5 integrin (ITGA5) as a functional target.
Main Results:
- miR-26a was found to promote anoikis in HCC cells.
- Alpha5 integrin (ITGA5) was identified as a direct target of miR-26a.
- Modulating ITGA5 levels affected miR-26a-induced anoikis in HCC cells.
Conclusions:
- miR-26a plays a novel role in promoting anoikis in hepatocellular carcinoma.
- ITGA5 is a functional target mediating miR-26a's pro-anoikis effect.
- miR-26a represents a potential therapeutic strategy for combating metastatic HCC.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs